Exploiting KRAS-mediated metabolic reprogramming as a therapeutic target.

Sanne Bootsma, Sanne M van Neerven, Louis Vermeulen

Journal: Nature genetics 2021;53(1):9-10

PMID: 33414546

Full Text on Nature Publishing Group View on PubMed

Abstract

Address: Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Oncode Institute Amsterdam, Amsterdam, the Netherlands.; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Amsterdam Gastroenterology and Metabolism, Amsterdam University Medical Centers, Amsterdam, the Netherlands. [email protected].; Oncode Institute Amsterdam, Amsterdam, the Netherlands. [email protected].

DOI: 10.1038/s41588-020-00758-y